HEADER TRANSCRIPTION/TRANSCRIPTION REGULATOR 24-SEP-10 3OZ0 TITLE PPAR DELTA IN COMPLEX WITH AZPPARD02 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NUCLEAR RECEPTOR PROTEIN, UNP RESIDUES 165-441; COMPND 5 SYNONYM: PPAR-DELTA, NUCI, NUCLEAR HORMONE RECEPTOR 1, NUC1, NUCLEAR COMPND 6 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2, PEROXISOME PROLIFERATOR- COMPND 7 ACTIVATED RECEPTOR BETA, PPAR-BETA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARD, NR1C2, PPARB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION FACTOR, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, KEYWDS 2 TRANSCRIPTION REGULATION, TRANSCRIPTION-TRANSCRIPTION REGULATOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.OGG REVDAT 4 06-SEP-23 3OZ0 1 REMARK SEQADV REVDAT 3 08-NOV-17 3OZ0 1 REMARK REVDAT 2 29-FEB-12 3OZ0 1 AUTHOR VERSN REVDAT 1 19-JAN-11 3OZ0 0 JRNL AUTH C.A.LUCKHURST,L.A.STEIN,M.FURBER,N.WEBB,M.J.RATCLIFFE, JRNL AUTH 2 G.ALLENBY,S.BOTTERELL,W.TOMLINSON,B.MARTIN,A.WALDING JRNL TITL DISCOVERY OF ISOINDOLINE AND TETRAHYDROISOQUINOLINE JRNL TITL 2 DERIVATIVES AS POTENT, SELECTIVE PPARδ AGONISTS JRNL REF BIOORG.MED.CHEM.LETT. V. 21 492 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21094606 JRNL DOI 10.1016/J.BMCL.2010.10.117 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.9 REMARK 3 NUMBER OF REFLECTIONS : 5457 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.900 REMARK 3 FREE R VALUE TEST SET COUNT : 536 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 404 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.59 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2101 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.73000 REMARK 3 B22 (A**2) : -2.05000 REMARK 3 B33 (A**2) : 0.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 4.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.529 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.391 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.567 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.861 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2137 ; 0.005 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1976 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2902 ; 0.825 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4568 ; 0.693 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 258 ; 4.271 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;30.219 ;24.130 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 360 ;14.575 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;17.174 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 335 ; 0.044 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2337 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 438 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 516 ; 0.177 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1964 ; 0.150 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1079 ; 0.172 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1107 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 42 ; 0.115 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 6 ; 0.091 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 47 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.125 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1705 ; 0.780 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 519 ; 0.094 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2103 ; 0.933 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 988 ; 1.276 ; 4.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 799 ; 1.929 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3OZ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-10. REMARK 100 THE DEPOSITION ID IS D_1000061749. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9134 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6381 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 56.490 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2GWX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG, PH 8.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 56.62900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.56700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 56.62900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.56700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 193 REMARK 465 GLY A 194 REMARK 465 HIS A 195 REMARK 465 HIS A 196 REMARK 465 HIS A 197 REMARK 465 HIS A 198 REMARK 465 HIS A 199 REMARK 465 HIS A 200 REMARK 465 GLY A 201 REMARK 465 SER A 202 REMARK 465 GLN A 203 REMARK 465 TYR A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 GLN A 207 REMARK 465 VAL A 208 REMARK 465 ALA A 209 REMARK 465 ASP A 210 REMARK 465 GLY A 239 REMARK 465 LYS A 240 REMARK 465 ALA A 241 REMARK 465 SER A 242 REMARK 465 HIS A 243 REMARK 465 THR A 244 REMARK 465 TYR A 477 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 224 CD CE NZ REMARK 480 LYS A 232 CG CD CE NZ REMARK 480 GLU A 253 CG CD OE1 OE2 REMARK 480 LYS A 260 CG CD CE NZ REMARK 480 LYS A 265 CD CE NZ REMARK 480 GLU A 291 CG CD OE1 OE2 REMARK 480 LYS A 336 CD CE NZ REMARK 480 LYS A 373 NZ REMARK 480 GLN A 429 CG CD OE1 NE2 REMARK 480 ARG A 455 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 457 CD CE NZ REMARK 480 LYS A 458 CD CE NZ REMARK 480 LYS A 474 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 258 93.94 -67.02 REMARK 500 GLU A 259 -77.71 -137.46 REMARK 500 LYS A 260 -15.05 58.21 REMARK 500 ASN A 269 -75.75 -119.24 REMARK 500 TYR A 274 -59.99 175.97 REMARK 500 SER A 305 -11.35 78.42 REMARK 500 ASP A 396 56.94 -93.31 REMARK 500 MET A 401 -72.53 -75.49 REMARK 500 ASP A 427 50.85 -95.39 REMARK 500 ALA A 428 77.79 -152.27 REMARK 500 ASP A 475 73.51 67.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3OZ A 1 DBREF 3OZ0 A 201 477 UNP Q03181 PPARD_HUMAN 165 441 SEQADV 3OZ0 MET A 193 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 GLY A 194 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 HIS A 195 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 HIS A 196 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 HIS A 197 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 HIS A 198 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 HIS A 199 UNP Q03181 EXPRESSION TAG SEQADV 3OZ0 HIS A 200 UNP Q03181 EXPRESSION TAG SEQRES 1 A 285 MET GLY HIS HIS HIS HIS HIS HIS GLY SER GLN TYR ASN SEQRES 2 A 285 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE SEQRES 3 A 285 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS SEQRES 4 A 285 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR SEQRES 5 A 285 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN SEQRES 6 A 285 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY SEQRES 7 A 285 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR SEQRES 8 A 285 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU SEQRES 9 A 285 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU SEQRES 10 A 285 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 11 A 285 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN SEQRES 12 A 285 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL SEQRES 13 A 285 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER SEQRES 14 A 285 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 15 A 285 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE SEQRES 16 A 285 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU SEQRES 17 A 285 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE SEQRES 18 A 285 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO SEQRES 19 A 285 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET SEQRES 20 A 285 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET SEQRES 21 A 285 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU SEQRES 22 A 285 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR HET 3OZ A 1 33 HETNAM 3OZ [4-({(1S)-1-[(2,4-DICHLOROPHENYL)CARBAMOYL]-1,3- HETNAM 2 3OZ DIHYDRO-2H-ISOINDOL-2-YL}METHYL)-2- HETNAM 3 3OZ METHYLPHENOXY]ACETIC ACID FORMUL 2 3OZ C25 H22 CL2 N2 O4 HELIX 1 1 LEU A 211 PHE A 226 1 16 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ASP A 251 ALA A 258 1 8 HELIX 4 4 GLY A 261 VAL A 268 1 8 HELIX 5 5 TYR A 274 ILE A 303 1 30 HELIX 6 6 PHE A 310 ALA A 331 1 22 HELIX 7 7 ARG A 350 SER A 355 1 6 HELIX 8 8 ARG A 357 ALA A 376 1 20 HELIX 9 9 ASP A 380 LEU A 393 1 14 HELIX 10 10 ASN A 402 HIS A 425 1 24 HELIX 11 11 TYR A 430 GLU A 460 1 31 HELIX 12 12 HIS A 466 LYS A 474 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 VAL A 341 -1 N VAL A 341 O GLY A 346 SHEET 4 A 4 VAL A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SITE 1 AC1 19 VAL A 281 PHE A 282 ARG A 284 CYS A 285 SITE 2 AC1 19 THR A 288 THR A 289 HIS A 323 PHE A 327 SITE 3 AC1 19 LEU A 330 VAL A 334 LEU A 339 VAL A 341 SITE 4 AC1 19 LEU A 353 ILE A 363 LYS A 367 HIS A 449 SITE 5 AC1 19 MET A 453 LEU A 469 TYR A 473 CRYST1 113.258 49.134 58.574 90.00 105.34 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008829 0.000000 0.002421 0.00000 SCALE2 0.000000 0.020353 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017703 0.00000